Stevanato Group S.p.A. (NYSE:STVN) Position Lessened by Stifel Financial Corp

Stifel Financial Corp decreased its holdings in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 50.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 45,925 shares of the company's stock after selling 46,462 shares during the period. Stifel Financial Corp's holdings in Stevanato Group were worth $918,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of STVN. Conestoga Capital Advisors LLC boosted its holdings in Stevanato Group by 5.5% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 7,675,910 shares of the company's stock worth $153,518,000 after acquiring an additional 400,087 shares during the period. Thrivent Financial for Lutherans grew its holdings in Stevanato Group by 67.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company's stock valued at $55,698,000 after purchasing an additional 1,123,104 shares in the last quarter. Bamco Inc. NY increased its stake in Stevanato Group by 1.3% during the 3rd quarter. Bamco Inc. NY now owns 1,685,181 shares of the company's stock worth $33,704,000 after buying an additional 21,469 shares during the period. Fred Alger Management LLC lifted its holdings in Stevanato Group by 24.2% in the 3rd quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company's stock worth $21,411,000 after buying an additional 208,830 shares in the last quarter. Finally, Pembroke Management LTD boosted its position in Stevanato Group by 143.7% in the 3rd quarter. Pembroke Management LTD now owns 1,051,140 shares of the company's stock valued at $21,023,000 after buying an additional 619,747 shares during the last quarter.

Stevanato Group Price Performance

Shares of NYSE:STVN traded down €0.02 ($0.02) on Tuesday, reaching €21.00 ($21.88). 165,500 shares of the company traded hands, compared to its average volume of 501,022. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The stock has a market capitalization of $6.21 billion, a PE ratio of 44.68, a P/E/G ratio of 10.49 and a beta of 0.59. The company's 50 day moving average is €20.10 and its 200-day moving average is €19.79. Stevanato Group S.p.A. has a fifty-two week low of €16.56 ($17.25) and a fifty-two week high of €34.73 ($36.18).

Stevanato Group (NYSE:STVN - Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing analysts' consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The firm had revenue of €277.90 million for the quarter, compared to analysts' expectations of €274.36 million. During the same period in the prior year, the company posted $0.16 earnings per share. Stevanato Group's quarterly revenue was up 2.4% compared to the same quarter last year. As a group, analysts anticipate that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on STVN shares. Morgan Stanley reaffirmed an "equal weight" rating and set a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Wolfe Research assumed coverage on shares of Stevanato Group in a report on Friday, December 13th. They issued an "outperform" rating and a $28.00 price objective for the company. Finally, Bank of America increased their target price on shares of Stevanato Group from $24.00 to $26.00 and gave the stock a "buy" rating in a report on Friday, December 13th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of €28.60 ($29.79).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.